|
MRS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-15 |
| Normal-vs-Stage2 |
7.78439999999936E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
5.55111512312578E-16 |
| Stage1-vs-Stage2 |
5.337200E-01 |
| Stage1-vs-Stage3 |
1.062020E-02 |
| Stage1-vs-Stage4 |
4.267500E-02 |
| Stage2-vs-Stage3 |
4.921600E-02 |
| Stage2-vs-Stage4 |
7.507500E-02 |
| Stage3-vs-Stage4 |
8.403000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.035820E-04 |
| Normal-vs-Asian |
4.404200E-01 |
| Caucasian-vs-AfricanAmerican |
2.241400E-01 |
| Caucasian-vs-Asian |
5.887800E-02 |
| AfricanAmerican-vs-Asian |
4.221600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.99109642504436E-11 |
| Male-vs-Female |
2.164200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.02019989415226E-10 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.15090004193519E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.630800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.746200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.203800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.226000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.410200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.639200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.079300E-03 |
| Normal-vs-Grade 2 |
1.62481139653892E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
2.184000E-01 |
| Grade 1-vs-Grade 3 |
1.685580E-01 |
| Grade 1-vs-Grade 4 |
1.558210E-02 |
| Grade 2-vs-Grade 3 |
5.781000E-01 |
| Grade 2-vs-Grade 4 |
1.174040E-02 |
| Grade 3-vs-Grade 4 |
4.262400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.89368570508486E-14 |
| Normal-vs-ccB subtype |
1.11022302462516E-16 |
| ccA subtype-vs-ccB subtype |
2.892100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55111512312578E-16 |
| Normal-vs-N1 |
4.334200E-02 |
| N0-vs-N1 |
6.907400E-01 |
|
|
